| Genome‐wide association studies of cognitive and motor progression in Parkinson's disease MMX Tan, MA Lawton, E Jabbari, RH Reynolds, H Iwaki, C Blauwendraat, ... Movement Disorders 36 (2), 424-433, 2021 | 133 | 2021 |
| Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease. MMX Tan, MA Lawton, E Jabbari, RH Reynolds, H Iwaki, C Blauwendraat, ... Wiley-Blackwell, 2021 | 133 | 2021 |
| Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome E Jabbari, N Holland, V Chelban, PS Jones, R Lamb, C Rawlinson, T Guo, ... JAMA neurology 77 (3), 377-387, 2020 | 126 | 2020 |
| Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study E Jabbari, S Koga, RR Valentino, RH Reynolds, R Ferrari, MMX Tan, ... The Lancet Neurology 20 (2), 107-116, 2021 | 84 | 2021 |
| Pathogenic Huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis R Dewan, R Chia, J Ding, RA Hickman, TD Stein, Y Abramzon, S Ahmed, ... Neuron 109 (3), 448-460. e4, 2021 | 68 | 2021 |
| Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype E Jabbari, J Woodside, MMX Tan, M Shoai, A Pittman, R Ferrari, KY Mok, ... Annals of neurology 84 (4), 485-496, 2018 | 53 | 2018 |
| Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes E Jabbari, J Woodside, T Guo, NK Magdalinou, V Chelban, D Athauda, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (7), 768-773, 2019 | 35 | 2019 |
| Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers E Jabbari, H Zetterberg, HR Morris Journal of Neurology, Neurosurgery & Psychiatry 88 (10), 883-888, 2017 | 33 | 2017 |
| Automated brainstem segmentation detects differential involvement in atypical parkinsonian syndromes M Bocchetta, JE Iglesias, V Chelban, E Jabbari, R Lamb, LL Russell, ... Journal of movement disorders 13 (1), 39, 2020 | 23 | 2020 |
| Tau-targeting antibody therapies: too late, wrong epitope or wrong target? E Jabbari, KE Duff Nature Medicine 27 (8), 1341-1342, 2021 | 22 | 2021 |
| The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy E Jabbari, J Woodside, MMX Tan, N Pavese, O Bandmann, BCP Ghosh, ... Movement Disorders 34 (9), 1307-1314, 2019 | 20 | 2019 |
| Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates H Ling, E Gelpi, K Davey, Z Jaunmuktane, KY Mok, E Jabbari, R Simone, ... Acta neuropathologica, 1-18, 2020 | 19 | 2020 |
| MAPT p. V363I mutation: A rare cause of corticobasal degeneration S Ahmed, MD Fairen, MS Sabir, P Pastor, J Ding, L Ispierto, A Butala, ... Neurology Genetics 5 (4), 2019 | 15 | 2019 |
| The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation AE Lang, GT Stebbins, P Wang, E Jabbari, R Lamb, H Morris, AL Boxer, ... Parkinsonism & Related Disorders 79, 121-126, 2020 | 12 | 2020 |
| Longitudinally extensive transverse myelitis: a rare association with common variable immunodeficiency E Jabbari, CR Marshall, H Longhurst, R Sylvester Practical neurology 15 (1), 49-52, 2015 | 11 | 2015 |
| Common variation at the LRRK2 locus is associated with survival in the primary tauopathy progressive supranuclear palsy E Jabbari, MMX Tan, RH Reynolds, KY Mok, R Ferrari, DP Murphy, ... bioRxiv, 2020 | 6 | 2020 |
| The clinical dilemma of treating transient ischaemic attack-like symptoms in patients with coexisting arteriovenous malformation E Jabbari, S Sethuraman, L Sekaran Case Reports 2014, bcr2013201315, 2014 | 3 | 2014 |
| [P1–258]: THE PROSPECT STUDY: DEVELOPMENT OF A UK‐BASED LONGITUDINAL OBSERVATIONAL STUDY OF PSP, CBD, MSA AND ATYPICAL PARKINSONISM SYNDROMES J Woodside, R Lamb, E Jabbari, V Chelban, D Burn, A Church, A Gerhard, ... Alzheimer's & Dementia 13 (7S_Part_7), P348-P348, 2017 | 2 | 2017 |
| Can CSF and plasma Neurofilament Light Chain predict disease progression in Progressive Supranuclear Palsy? E Jabbari, J Woodside, H Morris 21st International Congress of Parkinson's Disease and Movement Disorders, 2017 | 1 | 2017 |
| Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson disease N Vijiaratnam, M Lawton, A Heslegrave, T Guo, MMX Tan, E Jabbari, ... medRxiv, 2021 | | 2021 |
